市場調査レポート

世界の新規の腫瘍マーカー市場:市場分析と主要企業の戦略プロファイル

Tumor Markers, and Strategic Profiles of Leading Reagent and Instrument Suppliers

発行 Venture Planning Group 商品コード 251020
出版日 ページ情報 英文 286 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。

Local License: 同一事業所内

Back to Top
世界の新規の腫瘍マーカー市場:市場分析と主要企業の戦略プロファイル Tumor Markers, and Strategic Profiles of Leading Reagent and Instrument Suppliers
出版日: ページ情報: 英文 286 Pages
概要

当レポートでは、既存・新規の腫瘍マーカー検査関連の世界市場について分析し、市場全般および各部門の臨床上の重要性や市場ニーズを調査すると共に、主要サプライヤーの競争力(売上高、市品構成、マーケティング戦術、技術的ノウハウ、新製品の研究開発(R&D)状況、共同開発契約、事業戦略など)を分析し、さらに関連技術・製品・応用手法の開発に関与している大学・研究機関の一覧を盛り込んで、概略以下の構成でお届けします。

既存・新規の主ながん診断検査

  • イントロダクション
  • 腫瘍マーカーの分類
  • ACTH
  • αフェトプロテイン (AFP)
  • β2ミクログロブリン
  • CA 15-3/27.29
  • CA 19-9
  • CA-125
  • カルシトニン
  • がん胎児性抗原 (CEA)
  • エストロゲンおよびプロゲステロン受容体
  • フェリチン
  • ガストリン
  • ヒト絨毛性ゴナドトロピン (HCG)
  • インスリン
  • NSE
  • 潜血
  • 子宮頸がん検査/HPV
  • 前立腺酸性フォスファターゼ (PAP)
  • 前立腺特異抗原 (PSA)
  • 扁平上皮がん抗原 (SCC)
  • T/Bリンパ球
  • TdT
  • チログロブリン
  • 組織ポリペプチド抗原 (TPA)
  • 生物学的腫瘍マーカー(全4種)
  • がん遺伝子(全21種類)
  • ポリペプチド増殖因子(全10種)
  • 異所性ホルモン
  • コロニー刺激因子
  • リンフォカイン(全6種)
  • 免疫組織化学的染色
  • 新たな腫瘍マーカー(全33種)

競合企業のプロファイル

  • Abbott
  • AdnaGen
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Correlogic Systems
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • 栄研化学
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • 富士レビオ
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Ipsogen
  • Kreatech
  • 協和メデックス
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • タカラバイオ
  • Targeted Diagnostics & Therapeutics
  • 東ソー
  • Veridex
  • 和光純薬工業
  • Wallac/PE
  • Zila

付録

  • 付録I:がん診断技術とその活用法を開発している主な大学・研究機関

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPTM19060

This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.

The report includes an overview of the clinical significance and market needs for both current and emerging tumor markers, as well as extensive listings of companies, universities and research centers developing or marketing innovative technologies, products, and applications. 

The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 

Contains 286 pages and 28 tables

Table of Contents

Major Current And Emerging Cancer Diagnostic Tests

  • 1. Introduction
  • 2. Tumor Marker Classification
  • 3. ACTH
  • 4. Alpha-Fetoprotein (AFP)
  • 5. Beta-2 Microglobulin
  • 6. CA 15-3/27.29
  • 7. CA 19-9
  • 8. CA-125
  • 9. Calcitonin
  • 10. Carcinoembrionic Antigen (CEA)
  • 11. Estrogen and Progesterone Receptors
  • 12. Ferritin
  • 13. Gastrin
  • 14. Human Chorionic Gonadotropin (HCG)
  • 15. Insulin
  • 16. NSE
  • 17. Occult Blood
  • 18. PAP Smear/HPV
  • 19. Prostatic Acid Phosphatase (PAP)
  • 20. Prostate-Specific Antigen (PSA)
  • 21. Squamous Cell Carcinoma Antigen (SCC)
  • 22. T and B Lymphocytes
  • 23. TdT
  • 24. Thyroglobulin
  • 25. Tissue Polypeptide Antigen (TPA)
  • 26. Biochemical Tumor Markers
    • ADA
    • B-Protein
    • PNP
    • 5'-Nucleotidase
  • 27. Oncogenes
    • Abl/abl-bcr
    • AIB1
    • BCL-2
    • BRCA1
    • CD44
    • C-fos
    • C-myb
    • C-myc
    • CYP-17
    • Erb-B
    • HPC1
    • N-myc
    • P40
    • P51
    • P53
    • PIK3CA
    • PTI-1
    • Ras
    • Reg
    • Sis
    • Src
  • 28. Polypeptide Growth Factors
    • Basic Fibroblast Growth Factor
    • Beta-TGF
    • Cachectin (TNT)
    • Calmodulin
    • ECFR
    • Nerve Growth Factor (NGF)
    • Epidermal Growth Factor (EGF)
    • Ornithine Decarboxylase
    • Transferrin
    • Transforming Growth Factor-Alpha
  • 29. Ectopic Hormones
  • 30. Colony Stimulating Factors
  • 31. Lymphokines
    • Alpha-Interferon
    • B Cell Growth Factors
    • B Cell Growth Factor (BCGF)
    • Gamma-Interferon
    • Interleukin-1 (IL-1)
    • Macrophage Activating Factor
  • 32. Immunohistochemical Stains
  • 33. Emerging Tumor Markers
    • N-Acetylglucosamine
    • Actin
    • Alpha-Actin
    • Antineuronal Antibodies
    • 7B2
    • B72.3
    • Bax
    • BCD-F9
    • BLCA-4
    • Blood Group Antigens A,B,H
    • CA 50
    • CA 72-4/TAG-72
    • CA 195
    • CA-242
    • CA-549
    • CAM 26
    • CAR-3
    • Cathepsin-D
    • Chromogranin A and B
    • Cluster 1 Antigen
    • Cluster-5/5A Antigen
    • CTA
    • CU18
    • DR-70
    • DU-PAN-2
    • Endometrial Bleeding Associated Factor
    • Endostatin
    • Epithelial Membrane Antigen
    • Feulgen Hydrolysis
    • Fibronectin
    • FSH
    • (1->3)-L-fucosyltransferase
    • Gastrin-Releasing Peptide (GRP)
    • GDCFP-15
    • Glucagon
    • Glycoamines
    • H23
    • Her-2
    • Human Carcinoma Antigen
    • HPA
    • HSP27
    • Intermediate Filaments
    • Cytokeratins/CK18/Cyfra 21-1
    • Desmin
    • Gliofibrillary Acid Protein
    • Neurofilaments
    • Vimentin
    • KA 93
    • Kinases
    • KP16D3
    • LAI
    • Leukocyte Common Antigen
    • Lewis Antigens
    • Lysophosphatidic Acid (LPA)
    • Ma 695/Ma 552
    • MABDF3
    • MAG
    • ME1
    • Minactivin
    • MN/CA9
    • MSA
    • Mucin Cancer Antigen (MCA)
    • Multiple Tumor Suppressor 1
    • Myosin
    • NEA-130
    • NMP22
    • OA-519
    • Opiod Peptides
    • P-glycoprotein
    • Pancreatic Oncofetal Antigen (POA)
    • Placental Lactogen
    • PR92
    • Proliferative Index, Ki-67
    • Px
    • RB Inactivation/Deletion
    • Ret
    • SCCL 175
    • Selectin
    • Sialic Acid
    • Sialyl SSEA-1/SLX
    • SN10
    • Somatostatin
    • TA-90
    • TABA
    • Tachykinin
    • TAG 12
    • TPS
    • Troponin
    • Tubulin
    • VCAM
    • VEGF
    • Villen

Competitive Profiles

  • Abbott
  • AdnaGen
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Correlogic Systems
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Ipsogen
  • Kreatech
  • Kyowa Medex
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

Appendixes

  • Appendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technology and Applications

List of Tables

  • Tumor Marker Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or Marketing CA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications In Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Back to Top